Elhan Webb
Investor Relations Contact bij KARYOPHARM THERAPEUTICS INC.
Actieve functies van Elhan Webb
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | 14-03-2022 | - |
Loopbaan van Elhan Webb
Eerdere bekende functies van Elhan Webb
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ROCHE HOLDING AG | Public Communications Contact | - | - |
RUBIUS THERAPEUTICS | Investor Relations Contact | 01-11-2020 | - |
RADIUS HEALTH, INC. | Investor Relations Contact | 02-01-2018 | - |
Public Communications Contact | 02-01-2018 | - |
Opleiding van Elhan Webb
University of Southern California | Masters Business Admin |
Bogazici University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Zwitserland | 2 |
Turkije | 2 |
Operationeel
Investor Relations Contact | 3 |
Public Communications Contact | 2 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
KARYOPHARM THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Beurs
- Insiders
- Elhan Webb
- Ervaring